General Information of Drug (ID: DMNA9KW)

Drug Name
CCT251545 Drug Info
Synonyms
1661839-45-7; 8-(3-chloro-5-(4-(1-methyl-1H-pyrazol-4-yl)phenyl)pyridin-4-yl)-2,8-diazaspiro[4.5]decan-1-one; CHEMBL3408213; 8-[3-chloro-5-[4-(1-methylpyrazol-4-yl)phenyl]pyridin-4-yl]-2,8-diazaspiro[4.5]decan-1-one; CCT-251545; 8-{3-Chloro-5-[4-(1-Methyl-1h-Pyrazol-4-Yl)phenyl]pyridin-4-Yl}-2,8-Diazaspiro[4.5]decan-1-One; GTPL8945; SCHEMBL17113515; CHEBI:143114; AMY16654; BCP17378; EX-A2539; BDBM50073190; NSC784591; s7981; ZINC212373586; CCT 251545; CS-5359; NSC-784591; AC-31717; HY-12681; DB-119021; CCT 251545;CCT-251545; CCT-251545;CCT 251545; Q27075796; 2,8-Diazaspiro[4.5]decan-1-one, 8-[3-chloro-5-[4-(1-methyl-1H-pyrazol-4-yl)phenyl]-4-pyridinyl]-; 4TV; 8-[3-Chloro-5-[4-(1-methyl-1H-pyrazole-4-yl)phenyl]-4-pyridyl]-2,8-diazaspiro[4.5]decane-1-one
Cross-matching ID
PubChem CID
77050682
ChEBI ID
CHEMBL3408213
TTD Drug ID
D70HIN

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Steroid biosynthesis 2.03 0.00e+0 19/20 (95%) MSMO1;DHCR7;CYP51A1;...
Ribosome biogenesis in eukaryotes 2.01 7.12e-3 52/108 (48.15%) NOP10;HEATR1;NXT1;...
Mucin type O-glycan biosynthesis 1.87 1.19e-2 20/36 (55.56%) GALNT1;C1GALT1;GALNT12;...
Ferroptosis 1.86 8.89e-3 36/41 (87.8%) HMOX1;SLC7A11;SLC39A8;...
Nitrogen metabolism 1.79 2.56e-2 16/17 (94.12%) CA12;GLUL;CA2;...
Ribosome 1.77 2.49e-2 113/158 (71.52%) RPS5;RPL36;RPL14;...
Legionellosis 1.71 3.86e-2 51/57 (89.47%) CXCL3;CXCL8;CXCL1;...
Cysteine and methionine metabolism 1.71 3.65e-2 43/50 (86%) BCAT1;CBS;CTH;...
Complement and coagulation cascades 1.69 3.80e-2 76/85 (89.41%) SERPINB2;C1QB;CFB;...
RNA polymerase 1.67 4.20e-2 23/31 (74.19%) POLR1D;POLR3G;POLR3K;...
Focal adhesion -1.83 4.15e-2 180/201 (89.55%) SOS1;PIK3CD;FYN;...
Endocrine and other factor-regulated calcium reabsorpti... -1.85 2.76e-2 49/53 (92.45%) PRKCB;DNM2;ATP1B2;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 1.11uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 1.11uM - 10uM 24H